Participants:

Leonardo Angelone Deputy DirectorThe National Institutes on Drug Abuse

Other

Leonardo Angelone

Deputy DirectorThe National Institutes on Drug Abuse

Rick Bartels President/Founder DTxCC

Health Tech & Solutions

Rick Bartels

President/Founder DTxCC

Benjamin Alouf Chief Medical OfficerFloreo

Health Tech & Solutions

Benjamin Alouf

Chief Medical OfficerFloreo

Jess Lukacs Business Development Program OfficerThe National Institute on Drug Abuse (NIDA)

Other

Jess Lukacs

Business Development Program OfficerThe National Institute on Drug Abuse (NIDA)

Jordan Silberman Dir of Clinical Analytics & ResearchElevance Health

Other

Jordan Silberman

Dir of Clinical Analytics & ResearchElevance Health

Mark Prueter National Director, Employer & Benefit Strat.Otsuka Pharmaceuticals America

Other

Mark Prueter

National Director, Employer & Benefit Strat.Otsuka Pharmaceuticals America

Mark Grossman VP of Growth Initiatives & Market PartnersGoMo Health - Engagement that Works

Health Tech & Solutions

Mark Grossman

VP of Growth Initiatives & Market PartnersGoMo Health - Engagement that Works

Matt Norton VP of Marketing & Commercial DevelopmentS3 Connected Health

Professional Services

Matt Norton

VP of Marketing & Commercial DevelopmentS3 Connected Health

Ralph Morales III Managing DirectorShokunin Ventures

Startup

Ralph Morales III

Managing DirectorShokunin Ventures

Renae Beaumont Chief Operating OfficerRecovery Metrics

Startup

Renae Beaumont

Chief Operating OfficerRecovery Metrics

Ventsislav Dobrev Global Clinical Lead Digital BiomarkersRoche

Life Sciences, Pharma & Biotech

Ventsislav Dobrev

Global Clinical Lead Digital BiomarkersRoche

About this Meeting

Establishing the effectiveness of your solutions and securing reimbursement can be a daunting task. In the evolving reimbursement landscape, presenting a compelling value proposition and robust evidence base becomes crucial. However, not all payers demand the same type and level of evidence. This presents a significant hurdle for digital health companies who may operate on limited budgets as they design their evidence generation strategies.

To overcome these challenges, it is imperative for digital health innovators to explore effective pathways that align with evidence standards and provide efficient routes to national scale.

In this interactive session, we will delve into the evolving reimbursement landscape and unravel evidence demands of different payers. Considerations we will cover include:

How different payers evaluate the clinical and economic value of digital health solutions.
Strategies to align your evidence generation efforts with the specific requirements of each payer segment.
How to maximise your investment and future proof your evidence generation strategy.

We would like to remind you that our meetings are small and intimate sessions with a limited number of seats available, therefore we rely on your attendance and participation to ensure a high quality and valuable meeting for all. If you are confirmed for this meeting we ask if you can please ensure your attendance on the day.

The Future of Care Delivery: Defining a Real Clinical AI Strategy for What’s Next

How Health Plans Can Close the Gap Between AI Ambition and Data Reality

VIP Pass: Connecting leaders to transform healthcare!

Executive Masterclass - Big Tech, Big Bets: Where AI in Healthcare Actually Scales

Advancing High-Value Care Through Smarter Decision Support and Population Strategies

Growth in a Contracting Market

The Making of Petunia: Creativity, Risk and the Power of Play

Evidence Generation: What payers are looking for

Anchored by:

Participants:

About this Meeting

Featured:

The Future of Care Delivery: Defining a Real Clinical AI Strategy for What’s Next

Sponsored by:

How Health Plans Can Close the Gap Between AI Ambition and Data Reality

Sponsored by:

Featured:

VIP Pass: Connecting leaders to transform healthcare!

Executive Masterclass - Big Tech, Big Bets: Where AI in Healthcare Actually Scales

Featured:

Advancing High-Value Care Through Smarter Decision Support and Population Strategies

Sponsored by:

Growth in a Contracting Market

Sponsored by:

Featured:

Featured:

The Making of Petunia: Creativity, Risk and the Power of Play

Evidence Generation: What payers are looking for

Anchored by:

Participants:

Explore participants

About this Meeting